Tag: equity
-
Start-Ups Saying No Thanks to Venture Capital
Yesterday, we reported on 2018 being a banner year for venture capital, but the New York Times says a movement of entrepreneurs is looking for other ways to raise money.
-
Infographic – Venture Finance Reaching Dot-Com Levels
Venture funding last year totaled $99.5 billion, the largest annual outlay since 2000.
-
Spin-Off Gains Seed Funds for Non-Opioid Pain Drug
A company spun-off from a university medical materials lab received start-up funds to develop a non-opioid surgical pain therapy, including a clinical trial.
-
Lilly Buys Precision Cancer Company in $8B Deal
Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body.
-
Infographic – Nasdaq Biotech Index Recovers
We’ll check in from time to time on the Nasdaq Biotechnology Index that tracks 223 biotech industry stocks.
-
Infographic – Tech IPOs Flat in 2018
CB Insights recently issued its annual Tech IPO Report, showing the number of initial public stock offerings in the technology industries unchanged from 2017.
-
Drug Discovery Start-Up Gains $400M Financing
A 2 year-old company using computational techniques to find protein-targeting drugs raised $400 million in new financing, led by the venture funding arm of Softbank.
-
Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal
Eli Lilly and Co. is licensing a a treatment candidate for Alzheimer’s disease from biopharmaceutical company AC Immune that aims to block accumulation of tau proteins in the brain.
-
Nanotech Gene Therapy Company Raises $8.5M in Seed Funds
A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round.
-
RNA Biotech Raises $604M in IPO
Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million.